$ZVRA
ZEVRA THERAPEUTICS, INC.

2018 Q2 Form 10-Q Financial Statement

#000143774918015224 Filed on August 10, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.420M $3.570M
YoY Change -4.2% -16.78%
% of Gross Profit
Research & Development $10.49M $4.650M
YoY Change 125.55% -6.78%
% of Gross Profit
Depreciation & Amortization $90.00K $80.00K
YoY Change 12.5% 166.67%
% of Gross Profit
Operating Expenses $13.91M $8.224M
YoY Change 69.11% -11.33%
Operating Profit -$13.91M -$8.224M
YoY Change 69.11% -11.33%
Interest Expense $1.419M $1.443M
YoY Change -1.66% -2.17%
% of Operating Profit
Other Income/Expense, Net $3.876M $1.703M
YoY Change 127.6% -91.06%
Pretax Income -$10.03M -$6.521M
YoY Change 53.84% -166.79%
Income Tax -$39.00K -$4.000K
% Of Pretax Income
Net Earnings -$9.993M -$6.517M
YoY Change 53.34% -166.72%
Net Earnings / Revenue
Basic Earnings Per Share -$0.65 -$0.44
Diluted Earnings Per Share -$0.91 -$0.44
COMMON SHARES
Basic Shares Outstanding 15.32M 14.65M
Diluted Shares Outstanding 16.55M 14.65M

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.20M $53.50M
YoY Change -47.29% -35.23%
Cash & Equivalents $16.50M $12.39M
Short-Term Investments $11.70M $41.10M
Other Short-Term Assets $2.700M $1.900M
YoY Change 42.11% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables $0.00
Total Short-Term Assets $30.91M $55.36M
YoY Change -44.17% -34.53%
LONG-TERM ASSETS
Property, Plant & Equipment $1.841M $2.148M
YoY Change -14.29% 94.39%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.20M
YoY Change -40.74%
Other Assets $1.250M $321.0K
YoY Change 289.41% 189.19%
Total Long-Term Assets $3.091M $13.68M
YoY Change -77.41% -31.81%
TOTAL ASSETS
Total Short-Term Assets $30.91M $55.36M
Total Long-Term Assets $3.091M $13.68M
Total Assets $34.00M $69.05M
YoY Change -50.76% -34.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.00M $6.300M
YoY Change 122.22% 16.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.500M $200.0K
YoY Change 1650.0% -90.0%
Total Short-Term Liabilities $17.60M $6.592M
YoY Change 167.04% -10.81%
LONG-TERM LIABILITIES
Long-Term Debt $87.30M $92.00M
YoY Change -5.11% 1.77%
Other Long-Term Liabilities $743.0K $1.472M
YoY Change -49.52% 207.95%
Total Long-Term Liabilities $743.0K $1.472M
YoY Change -49.52% 207.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.60M $6.592M
Total Long-Term Liabilities $743.0K $1.472M
Total Liabilities $117.5M $108.3M
YoY Change 8.51% 3.86%
SHAREHOLDERS EQUITY
Retained Earnings -$200.9M -$144.2M
YoY Change 39.37% 47.14%
Common Stock $117.4M $104.9M
YoY Change 11.91% 6.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$83.55M -$39.28M
YoY Change
Total Liabilities & Shareholders Equity $34.00M $69.05M
YoY Change -50.76% -34.01%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$9.993M -$6.517M
YoY Change 53.34% -166.72%
Depreciation, Depletion And Amortization $90.00K $80.00K
YoY Change 12.5% 166.67%
Cash From Operating Activities -$9.150M -$6.470M
YoY Change 41.42% -21.77%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$40.00K
YoY Change -100.0% -73.33%
Acquisitions
YoY Change
Other Investing Activities $15.68M $6.080M
YoY Change 157.89% -115.08%
Cash From Investing Activities $15.68M $6.040M
YoY Change 159.6% -114.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.220M -60.00K
YoY Change -2133.33% -400.0%
NET CHANGE
Cash From Operating Activities -9.150M -6.470M
Cash From Investing Activities 15.68M 6.040M
Cash From Financing Activities 1.220M -60.00K
Net Change In Cash 7.750M -490.0K
YoY Change -1681.63% -98.99%
FREE CASH FLOW
Cash From Operating Activities -$9.150M -$6.470M
Capital Expenditures $0.00 -$40.00K
Free Cash Flow -$9.150M -$6.430M
YoY Change 42.3% -20.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
-15604000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1250000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
8224000
us-gaap Operating Expenses
OperatingExpenses
28677000
us-gaap Operating Expenses
OperatingExpenses
15604000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13908000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8224000
us-gaap Operating Income Loss
OperatingIncomeLoss
-28677000
CY2018Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
113000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
206000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
794000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
50000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20922000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112000
CY2018Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
743000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
143000
CY2018Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5626000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4376000
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 kmph Sale Of Securities Value Available To Issue
SaleOfSecuritiesValueAvailableToIssue
150000000
CY2018Q2 kmph Sale Of Stock Value Available To Issue
SaleOfStockValueAvailableToIssue
20000000
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
13967000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7875000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2005000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
117391000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
107209000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1380000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1165000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2659000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2254000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2195000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2220000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
780000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
780000
CY2018Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2017Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8828596
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11692975
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11899797
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11692975
CY2018Q2 us-gaap Assets
Assets
34000000
CY2017Q4 us-gaap Assets
Assets
52456000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
30909000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
46996000
CY2018Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
190000
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
189000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
284000
CY2018Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
466000
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
562000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16497000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10871000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11971000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17862000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17597000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13486000
CY2018Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12575694
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12618711
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15905146
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14657430
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15905146
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14657430
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
86845000
CY2017Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
89398000
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
CY2017Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3333000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3502000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
166000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
164000
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.56
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4179000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3693000
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5562000
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3523000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
11888000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
8311000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
11888000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
8311000
CY2018Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
17450000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11834000
CY2017Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7709000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4618000
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1610000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1662000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3992000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24911000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
32806000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
68000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4000
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1841000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2004000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
94000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
77000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10488000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4650000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22125000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8764000
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-200938000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164726000
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2017Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Share Based Compensation
ShareBasedCompensation
2659000
us-gaap Share Based Compensation
ShareBasedCompensation
2254000
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
598568
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
625466
CY2018Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22375
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23682
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9750
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9750
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-83545000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-57516000
CY2018Q2 us-gaap Undistributed Earnings
UndistributedEarnings
-9993000
CY2018Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP&nbsp;requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, including those related to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div></div></div></div></div></div>
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16548751
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14649586
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15056161
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14648291
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15317536
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14649586
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15056161
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14648291
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
60000
CY2018Q2 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
11888000
CY2018Q2 kmph Fair Value Adjustment Of Put Option Net Of Tax
FairValueAdjustmentOfPutOptionNetOfTax
-2923000
CY2018Q2 kmph Fair Value Adjustment Of Warrants Net Of Tax
FairValueAdjustmentOfWarrantsNetOfTax
-2615000
CY2018Q2 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
5562000
CY2017Q4 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
7709000
CY2017Q2 kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
3523000
kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-4179000
kmph Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-3693000
kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
3000
kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
7000
kmph Gain Loss On Subleases
GainLossOnSubleases
kmph Gain Loss On Subleases
GainLossOnSubleases
-102000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22847000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3420000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3574000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6552000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6840000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10032000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6521000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36259000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2318000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-51000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
101000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1030000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
151000
CY2018Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
79000
CY2018Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1152000
CY2018Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
123000
CY2017Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
13000
us-gaap Interest And Other Income
InterestAndOtherIncome
238000
us-gaap Interest And Other Income
InterestAndOtherIncome
114000
CY2018Q2 us-gaap Interest Expense
InterestExpense
1419000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-47000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4063000
CY2017Q2 us-gaap Interest Expense
InterestExpense
1443000
us-gaap Interest Expense
InterestExpense
2861000
us-gaap Interest Expense
InterestExpense
2884000
CY2018Q2 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
409000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52456000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17603000
us-gaap Interest Paid Net
InterestPaidNet
2863000
us-gaap Interest Paid Net
InterestPaidNet
2857000
CY2018Q2 us-gaap Liabilities
Liabilities
117545000
CY2017Q4 us-gaap Liabilities
Liabilities
109972000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34000000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11509000
CY2018Q2 us-gaap Long Term Investments
LongTermInvestments
CY2017Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11702000
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
31358000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3966000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-123000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24911000
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
3250000
CY2018Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15122000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3876000
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1703000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7582000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11741000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23251000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15994000
us-gaap Net Income Loss
NetIncomeLoss
-36212000
us-gaap Net Income Loss
NetIncomeLoss
-22839000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-9993000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6517000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9993000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
13908000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7243000

Files In Submission

Name View Source Status
0001437749-18-015224-index-headers.html Edgar Link pending
0001437749-18-015224-index.html Edgar Link pending
0001437749-18-015224.txt Edgar Link pending
0001437749-18-015224-xbrl.zip Edgar Link pending
ex_116600.htm Edgar Link pending
ex_116601.htm Edgar Link pending
ex_116602.htm Edgar Link pending
ex_116603.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmph-20180630.xml Edgar Link completed
kmph-20180630.xsd Edgar Link pending
kmph-20180630_cal.xml Edgar Link unprocessable
kmph-20180630_def.xml Edgar Link unprocessable
kmph-20180630_lab.xml Edgar Link unprocessable
kmph-20180630_pre.xml Edgar Link unprocessable
kmph20180630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending